RobertCharlesBucelliMDPhD

Neuromuscular Medicine

Associate Professor, Neurology, Washington University in St. Louis School of Medicine

Dr. Bucelli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1 Barnes Jewish Hospital Plz
# Div
Saint Louis, MO 63110
Phone+1 314-362-1408

Fax+1 314-362-3752

Washington University/B-JH/SLCH ConsortiumFellowship, Neuromuscular Medicine (Neurology), 2011 - 2012
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 2007 - 2011
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2007
Canisius CollegeB.S., Biology, Summa Cum Laude, 2001

Certified Clinical Neuromuscular Pathology United Council for Neurologic Subspecialties (UCNS), 2015
Eliasson Award for Teaching Excellence Department of Neurology, Washington University, 2013-2015
Medical Student Teaching Award Department of Neurology, Washington University, 2013, 2015
Distinguished Service Teaching Awards, Clinical Teacher of the Year Award Washington University, 2014
Medical Student Teaching Honor Roll Department of Neurology, Washington University, 2014
CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Administrative Chief Fellow Neuromuscular Division, Washington University, 2011
Certified Neurology ABPN, 2011
Co-recipient, The Leonard Berg Award for Resident Research Department of Neurology, Washington University, 2010
Herbert Schuel Research in Cell/Developmental Biology Award 2007
Alpha Omega Alpha National Honor Society 2007
Dean’s Letter of Commendation State University of New York at Buffalo, 2002-2003, 2006-2007
Excellence in Neuroscience Research Award Canisius College, 2001
Deans’ Honor List Canisius College, 1997-2001
Alpha Sigma Nu 2000
Research Award Recipient Howard Hughes Medical Institute, 2000
Excellence Program Research Award Canisius College, 1998-1999
All College Honors Program Canisius College, 1997
Join now to see all

PubMed

24 citations
Neurologic manifestations of intravascular large B-cell lymphoma
Pouya Tahsili-Fahadan, Armin Rashidi, Patrick J. Cimino, Robert C. Bucelli, Salah G. Keyrouz
Neurology. Clinical Practice. 2016-02-01
290 citations
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Timothy M. Miller, Merit Cudkowicz, Pamela J. Shaw, Peter M. Andersen, Nazem Atassi
The New England Journal of Medicine. 2020-07-08
68 citations
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study.
Michael Benatar, Joanne Wuu, Peter M Andersen, Robert C Bucelli, Jinsy A Andrews
Neurotherapeutics. 2022-07-01

Journal Articles

CANOMAD and Other Chronic Ataxic Neuropathies with Disialosyl Antibodies (CANDA)
R Brian Sommerville, Craig M Zaidman, Glenn Lopate, Alan Pestronk, Conrad C Weihl, Robert C Bucelli, Journal of Neurology
A young woman with blurred vision and distal paresthesias
Kung NH, Bartlett NL, Yaseen NR, Van Stavern GP, Bucelli RC, JAMA Neurology, 1/26/2015
Neurologic manifestations of intravascular large B-cell lymphoma
Tahsili-Fahadan P, Rashidi A, Cimino PJ, Bucelli RC, Keyrouz SG, Neurology Clinical Practice, 1/19/2015
Neuro-Sweet disease: A case of recurrent encephalitis and febrile neutrophilic dermatosis
Yuan K, Musiek AC, Schaffer A, Bucelli RC, Neurology Clinical Practice, 1/10/2015
Neuromuscular emergencies
Bucelli RC, Harms MB, Semin Neurol, 1/1/2015
Peripheral nervous system hyperexcitability in VV2 sporadic Creutzfeldt-Jakob disease
Ong CJ, Al-Lozi M, Cimino PJ, Bucelli RC, Neurology: Clinical Practice, 1/1/2015
Ocular neuromyotonia associated with chronic inflammatory demyelinating polyneuropathy
Kung NH, Bucelli RC, McClelland CM, Van Stavern GP, Neuro-Ophthalmology, 1/1/2015
Join now to see all

Hints That Experimental Drug Might Curb a Form of ALSSeptember 23rd, 2022
Longer-Term Use of Investigational Drug Stabilizes ALS SymptomsSeptember 22nd, 2022
Investigational Drug for Genetic Form of ALS Improves Disease’s Molecular SignsSeptember 21st, 2022
Join now to see all